Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter ended December 31, 2025.

BG Staffing Realigns Go-to-Market Strategy to Drive Greater Clarity and Effectiveness PLANO, TX / ACCESS Newswire / ...

March 12 (Reuters) - Allianz SE and Sun Life Financial are considering bids for HSBC's Singapore insurance unit after the ...

Topline data from 400-person sentinel cohort of the Phase 2b COVID-19 trial anticipated early Q2 2026 Published positive clinical results in the first quarter of 2026 demonstrating oral norovirus ...

BuzzFeed, the digital media empire that captured the attention of millennials in the mid-2010s, expressed "substantial doubt" Thursday about its ability to continue operations.

Patient dosing has commenced in first-of-its-kind Phase 3 head-to-head CAR T-cell 2L randomized controlled clinical trial (PiNACLE-H2H) in patients with large B-cell lymphoma, and the 3L+ pivotal ...

By Douglas Gillison, Gertrude Chavez-Dreyfuss and Michelle Price WASHINGTON/NEW YORK, March 12 (Reuters) - The day before U.S ...

Seasoned Finance Executive Brings Over 30 Years of Expertise to Lead Financial Strategy, Drive Profitable Growth and Enable ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) ('Plus” or the 'Company”), a healthcare company developing and commercializing ...

The trends we are seeing in the first quarter confirm that our strategy and execution are delivering measurable results,” said Lawrence Fey, Chief Executive Officer of Vivid Seats. “We are enhancing ...

Ramp reports that separating business and personal bank accounts is crucial to avoid legal, tax, and credibility risks for ...

Criminals are using AI and professional crime networks to scale attacks, yielding massive operational risks for banks, ...